Home » Topics » BioWorld Science

BioWorld Science
RSS

Pharmacyclics continues to advance multiple clinical development programs with Xcytrin

June 3, 2004

Array BioPharma highlights Q3 FY 2004 developments

June 3, 2004

Caspase -3 and -8 inhibition has therapeutic potential in lung transplantation

June 3, 2004

TAK-779, a novel immunosuppressant prolongs graft survival in mice

June 3, 2004

A novel JAK-3 inhibitor, NC-1153, increases graft survival and induces transplantation tolerance

June 3, 2004

New cannabinoid CB1 antagonists in early development at Pfizer

June 2, 2004

New FAAH inhibitors with potential utility as analgesic agents

June 2, 2004

Novel 5-HT6 receptor ligands identified by Roche scientists

June 2, 2004

Elan patent covers new bradykinin antagonists for pain and other uses

June 2, 2004

Scios researchers describe new p38alpha inhibitors

June 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...